UCB
The Access & Pricing Strategy Team Lead will combine strategic asset leadership with people leadership to shape payer, access, and pricing strategies that maximize patient access and long-term value across UCB's portfolio. This role involves leading a team of Access & Pricing Strategy Leads, acting as a strategic partner to Asset Payer Heads, and ensuring payer perspectives are integrated into development, evidence generation, and commercialization planning. The position requires collaboration with cross-functional stakeholders to drive global access strategy and operationalize strategic options across the asset lifecycle.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Director, Global Pricing and Market Access Strategy Lead Immunology
Bristol Myers Squibb
Director, Global Market Access and Pricing Strategy Oncology – Pumitamig
Bristol Myers Squibb
Director, Global Market Access and Pricing Strategy, Cell Therapy
Bristol Myers Squibb
Global Market Access Strategy, Franchise Head
BioLife Plasma Services
(Senior) Pricing and Access Manager - Oncology
Digital Biology
Director, Global Access Strategy & Pricing, Oncology Pipeline & BD
Pfizer